Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (141-150 of 270) with videos related to

Pageof 27
Sort By:
European Journal of Heart Failure|August 11, 2004
Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantationMiguel Angel Gómez-Sánchez, Carlos Saenz De La Calzada, Pilar Escribano Subías, et al.
BMC Pulmonary Medicine|December 23, 2019
Vitamin D deficiency among patients with pulmonary hypertensionAndrés N Atamañuk, Diego F Litewka, Sergio J Baratta, et al.
Archivos De Bronconeumologia|February 24, 2018
Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of RecommendationsJoan Albert Barberà, Antonio Román, Miguel Ángel Gómez-Sánchez, et al.
American Heart Journal|January 21, 2014
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertensionOlivier Sitbon, Marion Delcroix, Emmanuel Bergot, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata IsolatesMaría Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez-Carrillo, et al.
The American Journal of Cardiology|November 28, 2018
Frequency, Predictors, and Prognostic Impact of Pulmonary Artery Aneurysms in Patients With Pulmonary Arterial HypertensionJorge Nuche, José-Manuel Montero Cabezas, Carmen Jiménez López-Guarch, et al.
Seminars in Arthritis and Rheumatism|November 12, 2017
2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertensionBeatriz E Joven, Pilar Escribano, Jose Luis Andreu, et al.
Genes|May 28, 2022
Description of Two New Cases of <i>AQP1</i> Related Pulmonary Arterial Hypertension and Review of the LiteratureNatalia Gallego-Zazo, Alejandro Cruz-Utrilla, María Jesús Del Cerro, et al.
Mycoses|March 4, 2026
First Report of Fluconazole-Resistant Candida parapsilosis Harbouring the G458S ERG11p Substitution in a Brazilian HospitalSarah Santos Gonçalves, Simone Bravim Maifrede, Eduardo Yäkel, et al.
Journal of Clinical Medicine|February 12, 2020
Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial HypertensionMaria Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, et al.
Pageof 27

Showing results (141-150 of 270) with videos related to

Sort By:
Pageof 27
European Journal of Heart Failure|August 11, 2004
Pilot assessment of the response of several pulmonary hemodynamic variables to sublingual sildenafil in candidates for heart transplantationMiguel Angel Gómez-Sánchez, Carlos Saenz De La Calzada, Pilar Escribano Subías, et al.
BMC Pulmonary Medicine|December 23, 2019
Vitamin D deficiency among patients with pulmonary hypertensionAndrés N Atamañuk, Diego F Litewka, Sergio J Baratta, et al.
Archivos De Bronconeumologia|February 24, 2018
Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of RecommendationsJoan Albert Barberà, Antonio Román, Miguel Ángel Gómez-Sánchez, et al.
American Heart Journal|January 21, 2014
EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertensionOlivier Sitbon, Marion Delcroix, Emmanuel Bergot, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Mutant Prevention Concentration and Mutant Selection Window of Micafungin and Anidulafungin in Clinical Candida glabrata IsolatesMaría Ángeles Bordallo-Cardona, Laura Judith Marcos-Zambrano, Carlos Sánchez-Carrillo, et al.
The American Journal of Cardiology|November 28, 2018
Frequency, Predictors, and Prognostic Impact of Pulmonary Artery Aneurysms in Patients With Pulmonary Arterial HypertensionJorge Nuche, José-Manuel Montero Cabezas, Carmen Jiménez López-Guarch, et al.
Seminars in Arthritis and Rheumatism|November 12, 2017
2013 ACR/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertensionBeatriz E Joven, Pilar Escribano, Jose Luis Andreu, et al.
Genes|May 28, 2022
Description of Two New Cases of <i>AQP1</i> Related Pulmonary Arterial Hypertension and Review of the LiteratureNatalia Gallego-Zazo, Alejandro Cruz-Utrilla, María Jesús Del Cerro, et al.
Mycoses|March 4, 2026
First Report of Fluconazole-Resistant Candida parapsilosis Harbouring the G458S ERG11p Substitution in a Brazilian HospitalSarah Santos Gonçalves, Simone Bravim Maifrede, Eduardo Yäkel, et al.
Journal of Clinical Medicine|February 12, 2020
Total, Bioavailable, and Free Vitamin D Levels and Their Prognostic Value in Pulmonary Arterial HypertensionMaria Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, et al.
Pageof 27